Lyell Immunopharma (LYEL) News Today → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free LYEL Stock Alerts $2.61 +0.07 (+2.76%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 4:26 PM | markets.businessinsider.comBank of America Securities Keeps Their Buy Rating on Lyell Immunopharma (LYEL)May 12 at 3:30 AM | americanbankingnews.comLyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $2.68May 8, 2024 | marketbeat.comWuXi AppTec Co. Ltd. Takes Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL)WuXi AppTec Co. Ltd. purchased a new stake in shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 8,180,678 shares of the company's stock, valued at approMay 8, 2024 | americanbankingnews.comLyell Immunopharma's (LYEL) Buy Rating Reaffirmed at HC WainwrightMay 7, 2024 | globenewswire.comLyell Immunopharma to Participate in BofA Securities Health Care ConferenceMay 7, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Crispr Therapeutics AG (CRSP)May 7, 2024 | finance.yahoo.comLyell Immunopharma First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)May 7, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Stock Rating Reaffirmed by HC WainwrightHC Wainwright restated a "buy" rating and issued a $6.00 target price on shares of Lyell Immunopharma in a research note on Tuesday.May 6, 2024 | investorplace.comLYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q1 2024May 6, 2024 | globenewswire.comLyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024April 22, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading Up 5.8%Lyell Immunopharma (NASDAQ:LYEL) Trading 5.8% HigherApril 18, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading Down 4.6%Lyell Immunopharma (NASDAQ:LYEL) Trading Down 4.6%April 16, 2024 | morningstar.comLyell Immunopharma Inc Ordinary Shares LYELApril 15, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $3.01Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $3.01April 12, 2024 | benzinga.comArgan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On FridayApril 11, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading Up 4.9%Lyell Immunopharma (NASDAQ:LYEL) Trading Up 4.9%April 10, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Stock Price Down 7.5%Lyell Immunopharma (NASDAQ:LYEL) Shares Down 7.5%April 4, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading 4.9% Higher Lyell Immunopharma (NASDAQ:LYEL) Stock Price Up 4.9%April 4, 2024 | finance.yahoo.comOutpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual MeetingApril 2, 2024 | seekingalpha.comBiomea Fusion drops as JPMorgan downgrades on data for lead assetMarch 28, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading Up 5.9%Lyell Immunopharma (NASDAQ:LYEL) Shares Up 5.9%March 20, 2024 | finance.yahoo.com2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of DirectorsMarch 20, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $1.99Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down to $1.99March 17, 2024 | finance.yahoo.comLyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returnsMarch 13, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Gap Up to $2.18Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Up to $2.18March 11, 2024 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Shares Down 6.4% Lyell Immunopharma (NASDAQ:LYEL) Stock Price Down 6.4%March 10, 2024 | finanznachrichten.deLyell Immunopharma, Inc: Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual MeetingMarch 5, 2024 | globenewswire.comLyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual MeetingFebruary 28, 2024 | finance.yahoo.comLyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business HighlightsFebruary 28, 2024 | globenewswire.comLyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023February 26, 2024 | globenewswire.comLyell Immunopharma Announces Participation in March Investor ConferencesFebruary 20, 2024 | investing.comLyell Immunopharma Inc (LYEL)January 30, 2024 | benzinga.comLyell Immunopharma Stock (NASDAQ:LYEL) Dividends: History, Yield and DatesJanuary 3, 2024 | finance.yahoo.comLyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare ConferenceDecember 19, 2023 | health.usnews.comHeather D. LyellDecember 19, 2023 | finance.yahoo.comCompanies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In GrowthNovember 10, 2023 | seekingalpha.comLyell Immunopharma: Potential Solid Tumor Targeting With CAR-T And TILNovember 10, 2023 | markets.businessinsider.comWhy Lyell Immunopharma Shares Are Rising TodayNovember 9, 2023 | msn.comLyell gets FDA orphan drug designation for melanoma drug candidateNovember 9, 2023 | finance.yahoo.comLyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of MelanomaNovember 8, 2023 | msn.comLyell Immunopharma reports Q3 resultsNovember 7, 2023 | finance.yahoo.comLyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023October 31, 2023 | finance.yahoo.comLyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL ManufacturingOctober 9, 2023 | finance.yahoo.comLyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 49% stakeSeptember 27, 2023 | finance.yahoo.comLyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual MeetingSeptember 11, 2023 | marketwatch.comLyell Immunopharma Shares Up 8% on Cellares CollaborationSeptember 11, 2023 | finance.yahoo.comCellares and Lyell to Evaluate Automated Manufacturing of Lyell's CAR T-Cell Therapy on Cellares' Cell Shuttle PlatformSeptember 10, 2023 | marketbeat.comXTX Topco Ltd Has $676,000 Stake in Lyell Immunopharma, Inc. (NASDAQ:LYEL)XTX Topco Ltd raised its stake in Lyell Immunopharma, Inc. (NASDAQ:LYEL - Free Report) by 1,734.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 286,614 shares of the company's stock after buying an additional 270,98August 31, 2023 | finance.yahoo.comLyell Immunopharma to Participate in Upcoming Investor ConferencesAugust 29, 2023 | finance.yahoo.comAnalysts' Revenue Estimates For Lyell Immunopharma, Inc. (NASDAQ:LYEL) Are Surging Higher Get Lyell Immunopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LYEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Tiny AI projects with huge promise hiding in plain sight … (Ad)I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars. Click here to find out who they are. LYEL Media Mentions By Week LYEL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LYEL News Sentiment▼0.620.55▲Average Medical News Sentiment LYEL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LYEL Articles This Week▼51▲LYEL Articles Average Week Get Lyell Immunopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LYEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ORIC News PHAR News ZYME News SLN News OLMA News GHRS News CVAC News STOK News PAHC News CALT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LYEL) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersGold Set to EXPLODE!Gold Safe ExchangeRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
